Tweet
Dr. Gerami Seitzman at Sinai Hospital in Baltimore, who has a really impressive academic background, takes an incredibly multifaceted approach to the treatment of dry eye.
Her diagnostics are quite thorough, but MORE IMPORTANTLY, she is really game for trying a wide range of solutions, and does not limit her directions by whatever diagnosis emerges. In other words, where there are pain and surface sensitivity, she aggressively attempts to treat these, even when an exam shows a healthy-looking cornea and little or no inflammation. So often, this is our first hurdle in accessing successful care.
Dr. Seitzman is quite unique in being interested in collaborating with a patient's internist and/or pain/rehab physician, because she appears to be trying to master the systemic medications already in use to treat pain, in hopes of identifying medications that are helpful with eye pain.
Critical to her approach is her complete appreciation of the emotional devastation that dry eye can cause. This appreciation works its way into the treatment regimens that she offers.
Dr. Seitzman is already working with Leiter's Pharmacy in California, through which she arranges autologous serum for patients who are good candidates, and, possibly, other topical products unavailable through regular formularies.
I do not have the impression that Dr. Seitzman is yet familiar with Dr. Holly's research and products, but since she has already seen several DEZ participants, it is inevitable that she shall have the opportunity to see the responses that Dr. Holly's drops can produce in dry eye patients.
Dr. Seitzman was taking new patients, last I checked, and she may be reached at Phone (410) 601-5991 and Fax (410) 601-8273.
Her diagnostics are quite thorough, but MORE IMPORTANTLY, she is really game for trying a wide range of solutions, and does not limit her directions by whatever diagnosis emerges. In other words, where there are pain and surface sensitivity, she aggressively attempts to treat these, even when an exam shows a healthy-looking cornea and little or no inflammation. So often, this is our first hurdle in accessing successful care.
Dr. Seitzman is quite unique in being interested in collaborating with a patient's internist and/or pain/rehab physician, because she appears to be trying to master the systemic medications already in use to treat pain, in hopes of identifying medications that are helpful with eye pain.
Critical to her approach is her complete appreciation of the emotional devastation that dry eye can cause. This appreciation works its way into the treatment regimens that she offers.
Dr. Seitzman is already working with Leiter's Pharmacy in California, through which she arranges autologous serum for patients who are good candidates, and, possibly, other topical products unavailable through regular formularies.
I do not have the impression that Dr. Seitzman is yet familiar with Dr. Holly's research and products, but since she has already seen several DEZ participants, it is inevitable that she shall have the opportunity to see the responses that Dr. Holly's drops can produce in dry eye patients.
Dr. Seitzman was taking new patients, last I checked, and she may be reached at Phone (410) 601-5991 and Fax (410) 601-8273.
Comment